Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $501000.0.

  • Nuvation Bio's Cash from Financing Activities rose 13257.48% to $501000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $193.6 million, marking a year-over-year increase of 1422805.33%. This contributed to the annual value of $331000.0 for FY2024, which is 4729.3% down from last year.
  • Latest data reveals that Nuvation Bio reported Cash from Financing Activities of $501000.0 as of Q3 2025, which was up 13257.48% from $193.4 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Cash from Financing Activities peaked at $193.4 million during Q2 2025, and registered a low of -$1.5 million during Q3 2024.
  • In the last 3 years, Nuvation Bio's Cash from Financing Activities had a median value of $133000.0 in 2023 and averaged $17.8 million.
  • As far as peak fluctuations go, Nuvation Bio's Cash from Financing Activities tumbled by 209740.26% in 2024, and later surged by 693868.27% in 2025.
  • Nuvation Bio's Cash from Financing Activities (Quarter) stood at $120000.0 in 2023, then tumbled by 850.0% to -$900000.0 in 2024, then soared by 155.67% to $501000.0 in 2025.
  • Its last three reported values are $501000.0 in Q3 2025, $193.4 million for Q2 2025, and $548000.0 during Q1 2025.